Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the medical devices sector, is gaining attention from investors due to its promising growth trajectory and innovative product portfolio in the..
Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 47.36%. Headquartered in Shanghai, China, Zai Lab operates..
Alvotech (NASDAQ: ALVO), a Luxembourg-based pharmaceutical company specializing in biosimilar medicines, is capturing the attention of investors with a compelling potential upside of 69.33%. Operating in the highly dynamic healthcare..
MoonLake Immunotherapeutics (NASDAQ: MLTX) is carving out a strong niche in the biotechnology sector, commanding attention with its innovative approaches to treating inflammatory skin and joint diseases. Founded in 2021..
Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the competitive healthcare sector, specifically within the niche of Medicare Advantage plans targeting seniors. Headquartered in Orange, California, this innovative company has..
Investors focusing on biotechnology stocks should take a closer look at PTC Therapeutics, Inc. (NASDAQ: PTCT), a company that is making significant strides in the healthcare sector. With a market..
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a pioneering entity in the biotechnology sector, is capturing investor attention with its impressive growth trajectory and substantial upside potential. With a market capitalization..
Individual investors with a keen eye on the biotechnology sector may find Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) an intriguing prospect, particularly given its potential for substantial upside. With a market..
LivaNova PLC (LIVN) stands at the forefront of the medical device industry, carving out a niche with its innovative solutions for neurological and cardiac conditions. Headquartered in London, this healthcare..
As investors navigate the ever-evolving landscape of the biotechnology sector, Vericel Corporation (NASDAQ: VCEL) stands out with a compelling potential upside of 35.5%. This Cambridge, Massachusetts-based biopharmaceutical company specializes in..
Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, has captured investor attention with its significant potential upside. The company, headquartered in Dublin, Ireland, is a robust..
As the healthcare sector continues to captivate investor interest, ImmunityBio, Inc. (NASDAQ: IBRX) stands out with a market cap of $3.04 billion and a compelling 231.40% potential upside. This biotechnology..
Concentra Group Holdings Parent, Inc. (CON) stands as a compelling player in the healthcare sector, specifically within the medical care facilities industry. Based in Addison, Texas, the company focuses on..
Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector specializing in medical devices, presents a compelling investment case for individual investors. With a current market capitalization of $3.44..
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) has been capturing the attention of investors with its recent performance in the biotechnology sector, particularly with an enticing potential upside of 21.78%. Based in..
Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, is capturing investor attention with its promising potential upside of 47%. As it stands, the company is dedicated to developing novel..
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a pioneering force in the biotechnology sector, presents an intriguing investment opportunity for those with an appetite for innovation-driven growth. With a market capitalization of..
For investors keen on exploring opportunities within the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents a compelling case. With a market capitalization of $4.33 billion, Akero is positioned at..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its focus on rare neuroendocrine diseases. The company’s lead product, IMCIVREE (setmelanotide), is poised to tackle several..
